Sodium-glucose cotransporter 2 inhibitor use: A pharmaco-ergonomic qualification tool
Pharmaco-ergonomics implies tailoring the drug therapy to an individual patient's requirement(s). The development of sodium-glucose cotransporter 2 inhibitor (SGLT2-i) agents has impelled multiple clinical considerations, in the management of type-2 diabetes. This paper attempts to summarize the pha...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Wolters Kluwer Medknow Publications
2017-01-01
|
| Цуврал: | Indian Journal of Endocrinology and Metabolism |
| Нөхцлүүд: | |
| Онлайн хандалт: | http://www.ijem.in/article.asp?issn=2230-8210;year=2017;volume=21;issue=5;spage=762;epage=764;aulast=Kalra |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
